{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:18:15Z","timestamp":1789906695740,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2665-5","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T06:53:09Z","timestamp":1502261589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases"],"prefix":"10.1186","volume":"17","author":[{"given":"Kazuma","family":"Yagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-1664","authenticated-orcid":false,"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Asami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitake","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Funatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Uwamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatomo","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Betsuyaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"8","key":"2665_CR1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","volume":"185","author":"J Adjemian","year":"2012","unstructured":"Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"2665_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2334-13-231","volume":"13","author":"FC Ringshausen","year":"2013","unstructured":"Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW, Rademacher J, Suhling H, Wagner D, Welte T. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011. BMC Infect Dis. 2013;13:231.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2665_CR3","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","volume":"42","author":"W Hoefsloot","year":"2013","unstructured":"Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604\u201313.","journal-title":"Eur Respir J"},{"issue":"1","key":"2665_CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0033-1333567","volume":"34","author":"BA Kendall","year":"2013","unstructured":"Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34(1):87\u201394.","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"2665_CR5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan(1). Emerg Infect Dis. 2016;22(6):1116\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2665_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2665_CR7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","volume":"191","author":"BH Jeong","year":"2015","unstructured":"Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96\u2013103.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2665_CR8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","volume":"174","author":"DE Griffith","year":"2006","unstructured":"Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174(8):928\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2665_CR9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1513\/AnnalsATS.201604-246OC","volume":"13","author":"K Morimoto","year":"2016","unstructured":"Morimoto K, Namkoong H, Hasegawa N, Nakagawa T, Morino E, Shiraishi Y, Ogawa K, Izumi K, Takasaki J, Yoshiyama T, et al. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. Ann Am Thorac Soc. 2016;13(11):1904\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"2665_CR10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","volume":"38","author":"CA Peloquin","year":"2004","unstructured":"Peloquin CA, Berning SE, Nitta AT, Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis. 2004;38(11):1538\u201344.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2665_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","volume":"340","author":"BW Ramsey","year":"1999","unstructured":"Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev KM, Borowitz D, Bowman CM, Marshall BC, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med. 1999;340(1):23\u201330.","journal-title":"N Engl J Med"},{"key":"2665_CR12","first-page":"CD008319","volume":"12","author":"G Ryan","year":"2012","unstructured":"Ryan G, Jahnke N, Remmington T. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Cochrane Database Syst Rev. 2012;12:CD008319.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2665_CR13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","volume":"44","author":"AM Brodt","year":"2014","unstructured":"Brodt AM, Stovold E, Zhang L. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review. Eur Respir J. 2014;44(2):382\u201393.","journal-title":"Eur Respir J"},{"issue":"3","key":"2665_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","volume":"11","author":"BS Quon","year":"2014","unstructured":"Quon BS, Goss CH, Ramsey BW. Inhaled antibiotics for lower airway infections. Ann Am Thorac Soc. 2014;11(3):425\u201334.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2665_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.3.1.71","volume":"3","author":"JK Hagerman","year":"2006","unstructured":"Hagerman JK, Hancock KE, Klepser ME. Aerosolised antibiotics: a critical appraisal of their use. Expert Opin Drug Deliv. 2006;3(1):71\u201386.","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"2665_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","volume":"28","author":"DE Ghannam","year":"2009","unstructured":"Ghannam DE, Rodriguez GH, Raad II, Safdar A. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis. 2009;28(3):253\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2665_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","volume":"11","author":"KN Olivier","year":"2014","unstructured":"Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Siegelman JR, Shallom S, et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc. 2014;11(1):30\u20135.","journal-title":"Ann Am Thorac Soc"},{"key":"2665_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2466-7-2","volume":"7","author":"KK Davis","year":"2007","unstructured":"Davis KK, Kao PN, Jacobs SS, Ruoss SJ. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulmon Med. 2007;7:2.","journal-title":"BMC Pulmon Med"},{"issue":"8","key":"2665_CR19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s10096-011-1516-3","volume":"31","author":"A Safdar","year":"2012","unstructured":"Safdar A. Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis. Eur J Clin Microbiol Infect Dis. 2012;31(8):1883\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2665_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12931-015-0304-5","volume":"16","author":"T Asakura","year":"2015","unstructured":"Asakura T, Funatsu Y, Ishii M, Namkoong H, Yagi K, Suzuki S, Asami T, Kamo T, Fujiwara H, Uwamino Y, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16(1):145.","journal-title":"Respir Res"},{"issue":"4","key":"2665_CR21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/jac\/dkq536","volume":"66","author":"T Inagaki","year":"2011","unstructured":"Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates. J Antimicrob Chemother. 2011;66(4):722\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2665_CR22","doi-asserted-by":"crossref","unstructured":"Olivier KN, Griffith DE, Eagle G, McGinnis Ii JP, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, et al. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease. Am J Respir Crit Care Med. 2016;","DOI":"10.1164\/rccm.201604-0700OC"},{"key":"2665_CR23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12879-016-1689-6","volume":"16","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Morimoto K, Nishimura T, Tanaka H, Sugiura H, Yamada Y, Kurosaki A, Asakura T, Suzuki S, Fujiwara H, et al. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. BMC Infect Dis. 2016;16:396.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2665-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:10:36Z","timestamp":1569978636000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2665-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2665"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2665-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]},"article-number":"558"}}